Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03363100 · ClinicalTrials.gov registry record · NA
Diabetes Coaching Program for Medicare Advantage Members With Type 2 Diabetes - Impact on A1c
A NA study of Diabetes Mellitus, Type 2, sponsored by Evidation Health.
- Completed
- Registry status
- NA
- Development phase
- 624
- Enrollment target
- 1
- Study location
NCT03363100 is a NA study of Diabetes Mellitus, Type 2 that has completed, run by Evidation Health. The registered enrollment target is 624 participants, below the 4,484-participant average among 348 other Diabetes Mellitus, Type 2 trials with a reported enrollment target (86% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03363100, a NA study of Diabetes Mellitus, Type 2, has completed, sponsored by Evidation Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 624 participants
- Enrollment target
- 1
- Study location
Study Summary
The Diabetes Coaching Program for Medicare Advantage Members with Type 2 Diabetes - Impact on A1c trial is a 26-week long, prospective, intent-to-treat, 2-arm randomized controlled trial that aims to evaluate the impact of the Digital Health Partnership on A1c levels for individuals with uncontrolled Type 2 diabetes.
Conditions Studied
Interventions
- BEHAVIORAL Digital health Partnership program
Study Locations (1)
California
- Evidation Health - San Mateo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 624 participants |
| Start Date | 2017-12-05 |
| Est. Completion | 2019-02-23 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03363100
The ClinicalTrials.gov registry entry for NCT03363100 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 624 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,484-participant average among 348 other Diabetes Mellitus, Type 2 trials with a reported enrollment target (86% lower). The listed sponsor is Evidation Health, which has 12 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Diabetes Mellitus, Type 2 appearing as the primary indexed condition, and to 1 intervention - of which Digital health Partnership program is the first listed.
NCT03363100 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT03363100 about?
NCT03363100 is a clinical study titled "Diabetes Coaching Program for Medicare Advantage Members With Type 2 Diabetes - Impact on A1c". The Diabetes Coaching Program for Medicare Advantage Members with Type 2 Diabetes - Impact on A1c trial is a 26-week long, prospective, intent-to-treat, 2-arm randomized controlled trial that aims to evaluate the impact of the Digital Health Partnership on A1c levels for individuals with uncontrolle...
What is the current status of trial NCT03363100?
This trial is currently completed. It is a NA study. The enrollment target is 624 participants. The study started on 2017-12-05. Estimated completion is 2019-02-23.
What conditions does trial NCT03363100 study?
This clinical trial studies the following conditions: Diabetes Mellitus, Type 2.
What interventions are being tested in trial NCT03363100?
The interventions under investigation include: Digital health Partnership program (BEHAVIORAL).
Who is sponsoring clinical trial NCT03363100?
This trial is sponsored by Evidation Health, which has 12 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03363100 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetes Mellitus, Type 2
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Continuous Glucose Metrics in Patients With Gastroparesis in Type 1 or Type 2 Diabetes
RECRUITING · NA
-
Longitudinal Multi-Omic Profiles to Reveal Mechanisms of Obesity-Mediated Insulin Resistance
RECRUITING · NA
-
Trial to Assess Continuous Glucose Monitoring in Asian Americans With Type 2 Diabetes
RECRUITING · NA
-
Efficacy of mHealth Apps for Health in a Low-income, Type II Diabetic, Hispanic Population
RECRUITING · NA
-
Phenotyping Genetic Risk for Type 2 Diabetes
RECRUITING · NA
-
Diabetes Learning in Virtual Environments Just in Time for Community Reentry
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.